 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || LCAR-BCX cells / Legend Biotech
Enrollment closed: A Single-center Exploratory Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of a BCMA-targeted Universal LCAR-BCX Cells in Patients With Relapsed/Refractory Multiple Myeloma (clinicaltrials.gov) - Nov 1, 2021
P1, N=34, Active, not recruiting, Sponsor: Weijun Fu
Recruiting --> Active, not recruiting
- || LCAR-BCX cells / Legend Biotech
New P1 trial: A Single-center Exploratory Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of a BCMA-targeted Universal LCAR-BCX Cells in Patients With Relapsed/Refractory Multiple Myeloma (clinicaltrials.gov) - Oct 25, 2020
P1, N=34, Recruiting, Sponsor: Weijun Fu